Latest Nanogen Inc. (NGEN) Headlines 2013 Rep
Post# of 3
Posted On: 03/10/2014 6:46:06 PM
Latest Nanogen Inc. (NGEN) Headlines
2013 Report on the $13.1 Billion US In-Vitro Diagnostic Substance Manufacturing Industry and it's International Trade
M2 - Tue Feb 19, 2:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/5lnspg/invitro) has announced the addition of Supplier Relations US, LLC's new report "In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [2013 Edition]" to their offering. This latest In-Vitro Diagnostic Substance Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data, upstream and downstream industries, and trade data. The industry's revenue for the year 2011 was reported at $13.1 billion USD, with an estimated gross profit of 43.66%. The industry used a projected 44 percent of its full production capacity in 2011. The industry could have increased its total shipment value to $29.8 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a
2013 Report on the $13.1 Billion US In-Vitro Diagnostic Substance Manufacturing Industry and it's International Trade
M2 - Tue Feb 19, 2:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/5lnspg/invitro) has announced the addition of Supplier Relations US, LLC's new report "In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [2013 Edition]" to their offering. This latest In-Vitro Diagnostic Substance Manufacturing Industry report provides the most updated market research on the industry. Its scope contains analysis on the industry's key financial data, competitive landscape, shipment and inventory data, upstream and downstream industries, and trade data. The industry's revenue for the year 2011 was reported at $13.1 billion USD, with an estimated gross profit of 43.66%. The industry used a projected 44 percent of its full production capacity in 2011. The industry could have increased its total shipment value to $29.8 billion USD under full production capacity. This industry did not have direct foreign trade statistics. The report nevertheless depicted relevant foreign trade data from a
(0)
(0)Nanogen Inc. (NGEN) Stock Research Links
Scroll down for more posts ▼